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1072-98 Two Thousand Adults With Congenital Heart Disease: 
Operative and Nonoperative Mortality 
Carofe A. Warnes, Heidi M. Connolly, Francisco J. Puga, Gordon K. Danielson, Mayo 
C/inic, Rochester, Minnesota. 
Background: All 2000 adults with congenital heart disease (CHD) seen between 1987 - 
2000 were evaluated for an-cause mortality. 
Methods: Prospective data acquisition of all patients (pts) seen in the Adult CHD Clinic 
at a single center. 
Results: Of 2000 pts, age 13 - 85 yrs (mean 37.1), 752 (38%) were ~ 40 yrs old at refer- 
ral; 951 had never had surgery. One thousand and fifty-four operations were pedormed 
between 1987-2000. A total of 167 deaths (8%) occurred during follow-up (age 17- 89 
yrs, mean 42.9 ) Thirty-nine deaths (23%) were peri-operative (< 30-day: p-op); 3 p-op 
deaths occurred elsewhere. Eleven of our 36 p-op deaths (31%) occurred at initial opera- 
tion ;8 Ebstains (7 with advanced CHD at referral and 1 unexpected), and 3 complex pul- 
monary atresia (PA) (2 with advanced CHD and 1 sub-optimal selection). Of 25 deaths 
with re-operation (re-op), 12 had advanced CHD and were high-risk (3 with PA, 2 with 
aortic stenosis, 2 with single ventricle physiology and 1 each Ebstein, tetralogy, truncus, 
complex anomalous venous return and pulmonary hypertensive ductus/coarctation). 
Nine re-op deaths were unexpected (3 strokes, 2 bleeds, 2 cardiac failure (CHF), 1 rejec- 
tion after transplant and 1 spontaneous coronary dissection), 2 had sub-optimal selection 
(1 PA, 1 Fontan) and 2 had endocarditis. Seventeen p-op deaths occurred in pts having 
operation number _> 3 (range 3-8). Of 128 non-surgical deaths, 82 were expected cardio- 
vascular (CV) : 34 with advanced CHD, 27 with CHF and 21 with Eisenmenger syndrome 
(7 sudden). Twenty-three pts died suddenly (7 with tetralogy ).Four of these pts.(2 with d- 
transposition and 2 with tetralogy) had modest conduit obstruction. Nine pts died from 
cancer, 3 pts died after non-CV surgery (2 Eisenmenger, 1 Fontan ) and 10 from miscel- 
laneous causes. 
Conclualons: In this older cohort, a low op mortality is possible even in pts having multi- 
ple re-ops. Most p-op deaths (21/36, 58%) relate to advanced CHD and late referral 
Early recognition and referral to tertiary centers is recommended. Most non-surgical 
deaths also relate to advanced disease (82/128, 64%) although risk stratification for sud- 
den death remains a challenge. 
1072-99 How Important Is Cardiac MRI in the  Management  of  
Adults With Congenital Heart Disease? 
Jason L Infeld. Rola Saouaf, Gregory Pearson, Marion S. Rossnbaum, Columbia 
Universi~ New York, New York. 
Background: Assessment of RV function and complex anatomy with echocardiography in 
adults with congenital heart disease (CHD) can be difficult and may require other imaging 
modalities. Cardiac MRI is frequently used to answer these questions. We sought to 
determine the value of cardiac MRI in patients with insufficient echocardiographic infor- 
mation to determine its effect on subsequent management. Methods: We retrospectively 
reviewed all adults with CHD who underwent both echocardiography (Echo) and MRI at 
New York Presbyterian Hospital from 7/99 to 8/01. Indications for study were: (1) assess- 
ment of RV function (Group I) and (2) delineation of anatomy (Group II). Studies were 
pedormed on a 1.5T magnet utilizing cardiac gated spin echo and multiplanar cine with 
or without breath hold. Contrast enhanced MRA was utilized selectively to visualize arte- 
rial or venous abnormalities. Results: There were 66 pts (42M 24F) with a mean age of 
32 years (range 18-61). There were 28 pts in Group I; 23 with Tetralogy of Fallot (TOF) 
and pulmonary regurgitation and 5 with D or L-transposition of the great arteries. MRI 
was discordant with echo in 5 of 23 TOF pts (22%), all of whom had better RV function on 
MRI which delayed pulmonary valve replacement (PVR). In 6 additional pts (21%) in 
Group I, MRI revealed unsuspected anatomy that led to catheter intervention in 4. There 
were 38 pts in Group II, 12 of whom (32%) had MRI findings which led to catheter inter- 
vention, surgery or identification of a potential surgical problem. In 8 pts with prior coarc- 
ration repairs, MRI delineated the site for stent insertion in 5 and revealed an 
unsuspected false aneurysm in 2 pts requiring surgery. Overall, MRI resulted in catheter 
intervention or surgery in 14 of 66 pts (21%) and delayed PVR in 22% of TOF pts with 
pulmonary regurgitation. MRI failed to identify a venous anomaly in 2 pts referred for 
assessment of RV function in which MRA was not pedormed. Conclusions: In adults with 
CHD, cardiac MRI provides structural and functional information not obtainable with tran- 
sthoracic echocardiography that can lead to intervention or affect the decision for PVR. 
Use of MRI in selected lesions can facilitate the management of adults with CHD. 
1072-100 Beneficial Effects of Atrial Septal Defect Percutaneous 
Closure in Asymptomatic and Mildly Symptomatic 
Adults 
Marie-Claude Brochu. Jean-Francois Baril, Annie Dora, Martin Juneau, Pierre De Guise, 
Lise-Andr~e Mercier, Montreal Heart Institute, Montraa/, Quebec, Canada. 
Background: Controversy exists as to whether secundum type atrial septal defects (ASD) 
in asymptomatic or mildly symptomatic (NYHA I-II) adult patients (pts) should be closed. 
Methods: Twenty-two pts (15 females; mean age 48.5 years, 19 to 74) with a Qp/Qs of 
2.2/1 (1.4 to 3.4/1) had a VO2max determination and transthoracic echocardiogram 
before and 6 months after elective closure of ASD with an Amplatzer device. Short (SAX) 
and long (LAX) axis dimensions of the right ventricle were measured in the 4-chamber 
view. Right ventricular myocardial performance index (MPI) was calculated. 
Results: At baseline, mean VO2max was 25.1 cc/kg/min and was higher in NYHA I pts 
than in NYHA II pts (29.2 vs 21.9 cc/kg/min; p<0.02). Qp/Qs was higher in NYHA II pts; 
(2.4/1 vs 1.8/1; p<0.05) but there was no difference in right ventricular dimensions. 
VO2max increased significantly at 6 months (25.1 to 28.4 cc/kg/mJn; p=0.0002). 
improvement was as marked in the 9 NYHA I pts (+13.7%; from 29.3 to 33.1) as in the 13 
NYHA II pts (+12.3%; 21.9 to 24.6), in pts with Qp/Qs 1.4 to 2.0 (+11.7%) as in those with 
Qp/Qs greater or equal 2.0 (+12.4%) and in pts greater or equal 50 years (+11.7%) as in 
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those <50 years (+16.2%). Compared to 9•22 pts preprocedure, 21/22 pts were in NYHA 
I at 6 months. SAX decreased from 45 to 35 mm (p<0.0001) and LAX from 75 to 66 mm 
(p=0.0005). MPI was normal at baseline and at 6 months (0.20 to 0.36). 
Conclusion: 1) Adult ASD pts significantly increase their maximal 02 consumption after 
percutaneous defect closure. 
2) This can be observed even in pts classified as asymptomatic, in those with lesser 
shunts and in older pts. 
These findings suggest that ASD closure in an adult population with a Qp/Qs >1.4 should 
be considered even in the absence of symptoms. 
1072-101 Incidence of Infective Endarterltis in Adults With a 
Patent Ductus Arterioaus 
Michael J. Mullen. Courtney Powell, Peter R. McLaughlin, Gary Webb, Toronto General 
Hospita/, Toronto, Ontario, Canada. 
Background 
The contemporary risk of infective endarteritis (IE) in adult patients with a patent ductus 
arteriosus (PDA) is unclear. The aim of this study was to estimate the incidence of IE in 
adult patients with PDA and ascertain associated risk factors. 
Methods 
Patients with a diagnosis of PDA, not associated with complex congenital heart disease, 
were identified from the University of Toronto Congenital Cardiac Centre for Adults Cardi- 
ology database. Clinical records were reviewed to determine the prevalence of symp- 
toms, and arrhythmia, the presence of a typical murmur, and echocardiographic indices 
of left ventricular function. PDA size and morphology were determined angiographically 
in patients considered for device closure. Hospital records were reviewed to identify 
cases of possible or definite IE. Patients were considered at risk from age 16 until either 
closure of the PDA or latest clinical review. Logistic regression analysis was used to 
determine risk factors for IE. 
Results 
175 cases of PDA were identified (median age 37 [range 16-83] years, 79% female). A 
murmur was present in 70% although 57% were asymptomatic. Symptoms included dys- 
pnoea (40%) and palpitations (12%). Clinical heart failure and arrhythmia were present in 
8.2%. and 5.8% respectively. Five cases of definite IE were reported during a total of 
6897 years of follow-up though only 4 of these occurred during 4097 years of adult life 
(incidence 0.1%/year>16yrs old). All patients with IE had a murmur though one was 
asymptomatic with no evidence of left heart volume load on echocardiography. Duct 
sizes in patients with IE were 3.7, 4, 5.5, and 7.2 mm. No significant dsk factors for IE 
were identified from baseline data. 
Conclusion 
These data indicate a low risk of IE in adult patients with PDA. However, predicting those 
at risk from IE remains difficult and it may develop in patients with small PDAs and no 
clinical evidence of left heart volume load. 
1072-102 Heart Transp lantat ion  in Adolescents and Adults With 
Congenital Heart Disease 
Reema Chuah, Daniel Marelli, John S. Child, Bijst Patel, Joseph K. Perloff, Pamela D. 
Miner, Jon A. Kobashigawa, Barbara L. George, Hillel Laks, UCLA Medical Center, Los 
Angeles, California. 
Background: There are limited data on outcomes following heart transplantation in ado- 
lescents and adults with congenital heart disease (CHD). Accordingly, we assessed 
potential relationships between pro and post-transplantation risk factors and morbidity/ 
mortality. 
Methods: Twenty nine patients with congenital heart disease over age 13 years under- 
went orthotopic heart transplantation since 1984 out of a total of 1148 patients. Thirteen 
were aged 13 to 17 years, 16 were aged 18 to 49 years, and the mean age at transplan- 
tation was 23 years. The most frequent pre-transplant CHD diagnosis was single ventri- 
cle (n= 14) followed by d-transposition of the great arteries (n = 9). Twenty-seven of 29 
patients had 1 to 5 pdor cardiac operations (mean 2). Of the 27, 13 had a Fontan proce- 
dure, 3 had a Mustard or Senning procedure, and 11 had palliative shunts. The primary 
indication for transplantation was refractory heart failure. 
Results: Eady deaths occurred in 6/ 29 (20.6%), and late deaths occurred in 4/23 
(17.4%) during a mean follow up of 5.8 years. Four of 6 eady deaths were due to surgical 
bleeding mainly from extensive dissection, one to acute rejection, and one to refractory 
ventricular tachyarrhythmias. Extensive reconstruction significantly prolonged the 
ischomic time. Three of 4 late deaths were among the 4 patients who developed lym- 
phoproliferative disorders. The fourth late death was due to multi-organ failure following 
re-transplantation for transplant vasculopathy. More patients experienced recurrent epi- 
sodes of acute rejection in the first three years in contrast to transplant patients without 
congenital heart disease. 
Conclusions: Heart transplantation can be pedormed successfully in most adolescents 
and adults with congenital heart disease. However, an increased risk of bleeding is 
incurred because of extensive adhesions or collaterals. The higher rejection rate may be 
related to multiple blood transfusions during many pre-transplantation surgeries. Lym- 
phoprolfferative disorders may occur with increased frequency as a consequence of the 
combined effects of aggressive immunosuppresion and increased pra-transplantation 
radiation exposure. 
